Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba, Victor Seguritan, Weizhong Li, et al.
Cell Metabolism (2017) Vol. 25, Iss. 5, pp. 1054-1062.e5
Open Access | Times Cited: 928

Showing 1-25 of 928 citing articles:

Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3363
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2645
Non-alcoholic fatty liver disease
Elizabeth E. Powell, Vincent Wai‐Sun Wong, Mary E. Rinella
The Lancet (2021) Vol. 397, Iss. 10290, pp. 2212-2224
Closed Access | Times Cited: 1888
Gut microbiome and health: mechanistic insights
Willem M. de Vos, Herbert Tilg, Matthias Van Hul, et al.
Gut (2022) Vol. 71, Iss. 5, pp. 1020-1032
Open Access | Times Cited: 1497
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustı́n Albillos, Andrea De Gottardi, María Rescigno
Journal of Hepatology (2019) Vol. 72, Iss. 3, pp. 558-577
Open Access | Times Cited: 1433
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1292
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castéra, Mireen Friedrich‐Rust, Rohit Loomba
Gastroenterology (2019) Vol. 156, Iss. 5, pp. 1264-1281.e4
Open Access | Times Cited: 1186
The gut–liver axis and the intersection with the microbiome
Anupriya Tripathi, Justine W. Debelius, David A. Brenner, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 7, pp. 397-411
Open Access | Times Cited: 1124
Dietary lipids, gut microbiota and lipid metabolism
Marc Schoeler, Robert Caesar
Reviews in Endocrine and Metabolic Disorders (2019) Vol. 20, Iss. 4, pp. 461-472
Open Access | Times Cited: 878
The intestinal microbiota fuelling metabolic inflammation
Herbert Tilg, Niv Zmora, Timon E. Adolph, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 40-54
Closed Access | Times Cited: 806
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 787
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra, Gianluca Svegliati‐Baroni
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 280-295
Closed Access | Times Cited: 701
New insights from uncultivated genomes of the global human gut microbiome
Stephen Nayfach, Zhou Jason Shi, R. Seshadri, et al.
Nature (2019) Vol. 568, Iss. 7753, pp. 505-510
Open Access | Times Cited: 649
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles, José Manuel Fernández‐Real, Massimo Federici, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 1070-1080
Open Access | Times Cited: 591
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Giovanni Targher, Christopher D. Byrne, Herbert Tilg
Gut (2020) Vol. 69, Iss. 9, pp. 1691-1705
Open Access | Times Cited: 590
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease
Francesca Romana Ponziani, Sherrie Bhoori, Chiara Castelli, et al.
Hepatology (2018) Vol. 69, Iss. 1, pp. 107-120
Closed Access | Times Cited: 534
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
Vincent Wai‐Sun Wong, Leon A. Adams, Victor de Lédinghen, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 8, pp. 461-478
Closed Access | Times Cited: 532
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar‐Gómez, Naga Chalasani
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 305-315
Closed Access | Times Cited: 529
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
Juliette Mouriès, Paola Brescia, Alessandra Silvestri, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 6, pp. 1216-1228
Open Access | Times Cited: 519
Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice
Clea Bárcena, Rafael Valdés‐Mas, Pablo Mayoral, et al.
Nature Medicine (2019) Vol. 25, Iss. 8, pp. 1234-1242
Open Access | Times Cited: 515
Past, present and future perspectives in nonalcoholic fatty liver disease
Arun J. Sanyal
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 6, pp. 377-386
Closed Access | Times Cited: 469
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Ralf Weiskirchen, Sabine Weiskirchen, Frank Tacke
Molecular Aspects of Medicine (2018) Vol. 65, pp. 2-15
Closed Access | Times Cited: 464
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk, Danping Zheng, Oren Shibolet, et al.
EMBO Molecular Medicine (2018) Vol. 11, Iss. 2
Open Access | Times Cited: 452
Bile Acids Activated Receptors Regulate Innate Immunity
Stefano Fiorucci, Michele Biagioli, Angela Zampella, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 423
Gut microbes from the phylogenetically diverse genusEubacteriumand their various contributions to gut health
Arghya Mukherjee, Cathy Lordan, R. Paul Ross, et al.
Gut Microbes (2020) Vol. 12, Iss. 1, pp. 1802866-1802866
Open Access | Times Cited: 422
Page 1 - Next Page

Scroll to top